Nuts and Bolts of Surgical Management of Perihilar Cholangiocarcinoma – Part 2
SurgOnc Today®
In this episode of SurgOnc Today, live from SSO 2024, Dr. Alex Parikh from the University of Texas – San Antonio and Chair of the SSO HPB disease site working group, and Dr. Julie Hallet from the University of Toronto, and Vice-Chair of the SSO HPB disease site working group, are joined by Dr. Ana Gleisner from the University of Colorado and Dr. Skye Mayo from the Oregon Health and Sciences University. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: determining resectability as it relates to vascular involvement, and the role of...
info_outline
Management of High Grade Well Differentiated Neuroendocrine Tumors
SurgOnc Today®
In this episode of SurgOnc Today®, Sonia Orcutt, MD and Michail Mavros, MD, from the University of Arkansas for Medical Sciences are joined by Callisia N. Clarke, MD, MS, FACS, FSSO, Chief of the Division of Surgical Oncology at the Medical College of Wisconsin, and Alexandra Gangi, MD, FSSO, Director of the Gastrointestinal Tumor Program at Cedars Sinai Medical Center. The optimal treatment of high-grade well-differentiated neuroendocrine tumors has not been well-described, as they have only in recent years been identified as distinct from neuroendocrine carcinomas. The panelists discuss the...
info_outline
Nuts and Bolts of Surgical Management of Perihilar Cholangiocarcinoma – Part 1
SurgOnc Today®
In this episode of SurgOnc Today ®, Alex Parikh, MD, MPH, FACS, FSSO, from the University of Texas – San Antonio and Julie Hallet, MD, M.Sc., FRCSC, FSSO from the University of Toronto are joined by Monica M. Dua, MD, from Stanford University and Ching-Wei Tzeng, , MD, FACS, FSSO, from the MD Anderson Cancer Center. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: strategies for pre-operative optimization and biliary drainage, and management of the future liver remnant. This is part one of a two-part series.
info_outline
Screening Based on Risk Levels: What Tools Can We Use?
SurgOnc Today®
In this episode of SurgOnc Today®, Jennifer Plichta MD, Associate Professor of Surgery and Director of the Breast Risk Assessment Clinic at the Duke University Medical Center, is joined by Melissa Pilewskie, MD, Associate Professor of Surgery and Director of the Breast Care Center at the University of Michigan and Zahraa AlHilli, MD, MBA, Interim Director of the Breast Center and Co-Director of the Comprehensive Breast Program at Cleveland Clinic. Given the continuous advancements in breast imaging and risk assessment, it is important to be familiar with the latest imaging modalities, the...
info_outline
Management of Locally Advanced Extremity Sarcoma
SurgOnc Today®
The management of locally advanced extremity soft tissue sarcomas require a multidisciplinary approach. Surgery remains the standard of care for cure, however, other loco-regional treatments including radiation and isolated limb perfusion as well as systemic treatments have been utilized to reduce local and distant recurrence risk. In this podcast, we will focus on the multidisciplinary approach for locally advanced extremity sarcomas. We will highlight the role of limb-sparing resections versus amputations.
info_outline
Getting the Most Out of ERAS Pathways for Patients Undergoing Gastric Cancer Surgery
SurgOnc Today®
In this episode of SurgOnc Today®, Gautam Malhotra, MD, interviews Jeremy L. Davis, MD, Mio Kitano, MD, and Sonia Orcutt, MD, live at SSO 20204 after their panel discussion on “Getting the Most out of ERAS Pathways for Patients Undergoing Gastric Cancer Surgery”. They review the current literature on the use of ERAS for gastric cancer surgery, the importance of multi-disciplinary approach, and the challenges in the implementation.
info_outline
Preparation and Training for Pelvic Exenterative Surgery
SurgOnc Today®
This episode of SurgOnc Today®, recorded at SSO 2024, focuses on understanding the training and preparation needed prior to embarking on pelvic exenterative surgery and international collaboration to improve the outcomes of complex pelvic resections.
info_outline
SSO Women in Cancer Surgery - Women's History Month
SurgOnc Today®
In this episode of SurgOnc Today, Sarah McLaughlin, MD, interviews renowned surgical oncologists Lisa Newman, MD, MPH, and Monica Morrow, MD, to get their perspectives on how women’s experiences with medical school, surgical training, and professional career trajectories have evolved during their time in medicine.
info_outline
Only Merkel Cells in the Building
SurgOnc Today®
In this episode for SurgOnc Today, Jeffrey Farma, MD, from Fox Chase Cancer Center/Temple Health in Philadelphia, PA, interviews James Jakub, MD, from Mayo Clinic Jacksonville, FL and Luke Rothermel, MD, MPH, from University Hospitals-Cleveland Medical Center Cleveland, OH. We will review the current updates on the evaluation, workup and treatment of patients with Merkel cell carcinoma. This will include the surgical management, current trends on both neoadjuvant and adjuvant therapy, recurrence and surveillance strategies.
info_outline
Pancreatic Watch: Is Observation of Non-Functional Sporadic Small PNETs Safe?
SurgOnc Today®
In this episode of SurgOnc Today®, Julie Hallet, MD, MSc, FRCSC, FSSO, from the University of Toronto and Vice-Chair of the SSO HPB disease site working group is joined by Stefano Partelli, MD, PhD, from Università Vita-Saluta San Raffaele and Els Nieveen van Dijkum, MD, PhD, from Amsterdam UMC. We will delve into the rationale behind the non-operative management of non-functional sporadic pancreatic neuroendocrine tumors (PNETs) as well as the design and results of two prospective studies, ASPEN and PANDORA. Show Notes: PANDORA: ASPEN (interim analysis):
info_outlineIn this episode of SurgOnc Today, Sarah McLaughlin, MD, interviews renowned surgical oncologists Lisa Newman, MD, MPH, and Monica Morrow, MD, to get their perspectives on how women’s experiences with medical school, surgical training, and professional career trajectories have evolved during their time in medicine.